SAN JOSE, Calif.--(BUSINESS WIRE)--Nodexus Inc., a leader in automated benchtop single-cell characterization and microfluidic isolation technologies, today announced that three leading experts in cytometry sciences, pathology, and cancer biology have joined its Scientific Advisory Board (SAB). The Nodexus SAB is chaired by Professor Jonni Moore, PhD, one of the world’s leading experts in flow cytometry, laboratory medicine, and cellular immunology..

加利福尼亚州圣何塞——（商业新闻短讯）——自动化台式单细胞表征和微流体分离技术的领导者Nodexus Inc.今天宣布，三位细胞计数科学、病理学和癌症生物学领域的领先专家加入了其科学顾问委员会（SAB）。Nodexus SAB由Jonni Moore教授担任主席，Jonni Moore博士是流式细胞术，实验室医学和细胞免疫学领域的世界领先专家之一。。

The SAB will provide strategic direction and guidance for commercial expansion and product innovation to help Nodexus on its mission to accelerate cell biology workflows and make them universally accessible. Nodexus’ NX One single-cell isolation system is quickly emerging as a critical component for cell line and antibody development, CRISPR and protein engineering, synthetic biology, and single-cell genomics, among other rapidly growing applications, and the company’s SAB aims to accelerate further adoption of Nodexus platforms..

SAB将为商业扩张和产品创新提供战略方向和指导，以帮助Nodexus加速细胞生物学工作流程并使其普遍可用。Nodexus的NX One单细胞分离系统正在迅速成为细胞系和抗体开发，CRISPR和蛋白质工程，合成生物学和单细胞基因组学以及其他快速增长的应用的关键组件，该公司的SAB旨在加速进一步采用Nodexus平台。。

“We are excited to have some of the world’s foremost experts in cytometry join our SAB, and we are confident that the breadth of knowledge that Jonni, John, and Peter bring to Nodexus will enable us to drive innovation for single-cell workflows,” said Karthik Balakrishnan, PhD, Founder and CEO of Nodexus.

Nodexus创始人兼首席执行官Karthik Balakrishnan博士说：“我们很高兴有世界上最顶尖的细胞计数专家加入我们的SAB，我们相信Jonni，John和Peter为Nodexus带来的广泛知识将使我们能够推动单细胞工作流程的创新。”。

“With the support of our SAB, we’re dedicated to providing advanced capabilities and value to scientists – all at a price that every lab can afford. Our stellar group of scientific advisors will lead us in providing transformational advancements in cell biology.”.

“在SAB的支持下，我们致力于为科学家提供先进的能力和价值-所有这些都是每个实验室可以承受的价格。我们的一流科学顾问团队将带领我们在细胞生物学方面提供变革性的进步。”。

The new members of the SAB include:

SAB的新成员包括：

Chairperson: Jonni S. Moore, PhD – Professor of Pathology and Laboratory Medicine at the Hospital of the University of Pennsylvania and the Perelman School of Medicine. Dr. Moore has pioneered new technology in flow cytometry liquid biopsies, including the detection of extracellular vesicles as a rich source of prognostic and diagnostic information and developing this technology for diagnostics / prognostics in cardiovascular disease, traumatic brain injury, and relapsing breast cancer.

主席：Jonni S.Moore博士，宾夕法尼亚大学医院和佩雷尔曼医学院病理学和检验医学教授。摩尔博士开创了流式细胞术液体活检的新技术，包括检测细胞外囊泡作为预后和诊断信息的丰富来源，并开发了这项技术用于心血管疾病，创伤性脑损伤和复发性乳腺癌的诊断/预后。

More recently, she has focused on the development of high dimensional deep phenotyping approaches for the identification of biomarkers of cancer responses using advanced analytical technologies. In addition to her academic positions, Dr. Moore is widely known for her work as the former President of the International Society of Cytometry (ISAC)..

最近，她专注于开发高维深度表型分析方法，以使用先进的分析技术鉴定癌症反应的生物标志物。除了她的学术职位外，摩尔博士还因其作为国际细胞计数学会（ISAC）前主席的工作而广为人知。。

Peter A. Lopez – Vice President, Technical Operations and Innovations, New York Site Head, Comprehensive Cell Solutions, New York Blood Center and Associate Professor in the Department of Pathology at the New York University Grossman School of Medicine. Mr. Lopez has been a leading innovator in the field of flow cytometry for over four decades, and his focus has been to help facilitate the use of cytometry to answer critical biological questions such as the impacts of sorter-induced cellular stress (SICS) and its detrimental effects on the processes of cellular metabolism.

Peter A.Lopez–技术运营与创新副总裁，纽约血液中心综合细胞解决方案纽约站点负责人，纽约大学格罗斯曼医学院病理学系副教授。40多年来，洛佩兹先生一直是流式细胞仪领域的领先创新者，他的重点是帮助促进细胞仪的使用，以回答关键的生物学问题，例如分选机诱导的细胞应激（SIC）的影响及其对细胞代谢过程的不利影响。

He has applied his extensive cytometric expertise to a wide range of studies, including the automated detection of malignant or premalignant cells, hematopoietic stem cell isolation, the study of T-cell receptor function, the detection and study of apoptotic cells, and the investigation of HIV infection in varied cell types.

他将其广泛的细胞计量学专业知识应用于广泛的研究，包括恶性或癌前细胞的自动检测，造血干细胞分离，T细胞受体功能的研究，凋亡细胞的检测和研究，以及各种细胞类型中HIV感染的调查。

Mr. Lopez currently oversees technical operations for the manufacturing of innovative cell therapeutics..

Lopez先生目前负责创新细胞疗法制造的技术运营。。

John Ferbas, PhD – Director, Cytometry Sciences at Amgen, Inc. Dr. Ferbas has had a highly distinguished career in the pharmaceutical industry, leveraging cutting-edge technologies for cellular characterization and isolation, as well as advancing educational outreach programs that contribute to innovation.

John Ferbas博士，Amgen，Inc.细胞计数科学主任。Ferbas博士在制药行业拥有卓越的职业生涯，利用尖端技术进行细胞表征和分离，并推进有助于创新的教育推广计划。

He has a 25+ year tenure at Amgen and currently serves as a Director in the Department of Discovery Biological Sciences for therapeutic discovery and precision biology. Prior to Amgen, Dr. Ferbas was an Assistant Professor of Medicine at the University of California, Los Angeles School of Medicine. He is a founding member of the Southern California Flow Cytometry Association (SoCal Flow) and the American Association of Pharmaceutical Scientists (AAPS) PharmaFlow Working Group..

他在安进拥有25年以上的任期，目前担任发现生物科学系治疗发现和精密生物学系主任。在安进之前，费尔巴斯博士是加州大学洛杉矶分校医学院的助理教授。他是南加州流式细胞术协会（SoCal Flow）和美国药物科学家协会（AAPS）PharmaFlow工作组的创始成员。。

“I’m extremely pleased to serve as the Chairperson of Nodexus’ Scientific Advisory Board,” said Dr. Moore. “The technological innovation that Nodexus has developed to simplify and democratize single-cell sorting and dispensing has the potential for far-ranging impact across translational research and the pharma and biotech industries.

摩尔博士说：“我非常高兴能担任诺迪斯科学顾问委员会的主席。”。“Nodexus为简化和民主化单细胞分选和分配而开发的技术创新有可能对转化研究以及制药和生物技术行业产生深远影响。

I look forward to working with my distinguished SAB colleagues, Nodexus’ senior leadership and Board of Directors, and its talented R&D and commercial teams to develop and deploy cost-effective technology platforms to accelerate scientific discovery and cell biology workflows globally.”.

我期待着与我尊敬的SAB同事、Nodexus的高级领导层和董事会以及其才华横溢的研发和商业团队合作，开发和部署具有成本效益的技术平台，以加速全球科学发现和细胞生物学工作流程。”。

About Nodexus

关于Nodexus

Nodexus is a life science tools company that develops platforms to accelerate biological workflows and make them widely accessible. The company leverages a proprietary technology suite consisting of contamination-free microfluidic cartridges, hardware instruments, and software offerings. Nodexus’ flagship NX One platform offers integrated, easy-to-use, and affordable automated cell isolation for applications in industry, clinical research, and academia, including cell line and antibody development, CRISPR engineering, single-cell genomics, synthetic biology, and more.

Nodexus是一家生命科学工具公司，开发平台以加速生物工作流程并使其广泛可用。该公司利用由无污染微流体墨盒、硬件仪器和软件产品组成的专有技术套件。Nodexus的旗舰NX One平台为工业，临床研究和学术界的应用提供了集成，易于使用且价格合理的自动细胞分离，包括细胞系和抗体开发，CRISPR工程，单细胞基因组学，合成生物学等。

For more information regarding the company and the NX One, please visit Nodexus..

有关该公司和NX One的更多信息，请访问Nodexus。。